Clough Capital Partners L P Tekla Life Sciences Investors Transaction History
Clough Capital Partners L P
- $878 Million
- Q1 2024
A detailed history of Clough Capital Partners L P transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Clough Capital Partners L P holds 119,640 shares of HQL stock, worth $1.69 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
119,640
Previous 375,410
68.13%
Holding current value
$1.69 Million
Previous $5.05 Million
67.74%
% of portfolio
0.19%
Previous 0.57%
Shares
6 transactions
Others Institutions Holding HQL
# of Institutions
80Shares Held
8.51MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.46MShares$34.7 Million0.58% of portfolio
-
Morgan Stanley New York, NY484KShares$6.83 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA481KShares$6.79 Million0.54% of portfolio
-
Allspring Global Investments Holdings, LLC431KShares$6.08 Million0.01% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT387KShares$5.46 Million0.32% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...